Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study

By afschroeder • September 20, 2025

Frost S, Ambastha C, Patel D, Roney A, Greb A, Rangel-Garcia M, Sauk JS, Chang C, Park S, Parian A, Suchan A, Moughames E, Krishna M, Chowdhury R, Sharma S, Maas L, Ho A, Lazarev M, Limketkai BN, Limsui D, Keyashian K. Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study. Inflamm Bowel Dis. 2025 Sep 15:izaf170. doi: 10.1093/ibd/izaf170. Epub ahead of print. PMID: 40971840.

Tags: Digestive Diseases, General Internal Medicine, Publications, Resident

Translated Educational Infographics Increase Colorectal Cancer Screening Rates in Non-Native English Speakers

Zhornitskiy A, Nguyen BS, Shieh C, Nasirishargh A, Valenti L, Perez JLM, Zhornitsky F, Do T, Nguyen JT, Jeong S, Hsu R. Translated Educational Infographics[...]

JPEN Journal Club 98. When to select an outcome

Koretz RL. JPEN Journal Club 98. When to select an outcome. JPEN J Parenter Enteral Nutr. 2026 Jan 20. doi: 10.1002/jpen.70057. Epub ahead of print.[...]

Hepatorenal Syndrome in Focus: Emerging Diagnostic Criteria and Current Therapeutic Approaches

Chandna S, Baniqued MR, Harmon R, Chan P, Wang J, Patel JH. Hepatorenal Syndrome in Focus: Emerging Diagnostic Criteria and Current Therapeutic Approaches. J Clin[...]